Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carprofen in osteoarthrosis.

B Klein

    European Journal of Rheumatology and Inflammation
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Carprofen demonstrates effectiveness and good tolerability for osteoarthrosis treatment. Two trials suggest a slight advantage for carprofen over ibuprofen and a twice-daily dosing schedule over three times daily.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Numerical simulation of vertical cavity surface emitting lasers.

    Optics express·2009
    Same author

    [Colonic perforation after extracorporeal shock wave lithotripsy].

    Deutsche medizinische Wochenschrift (1946)·2009
    Same author

    Thyroid surgery in Burkina Faso, West Africa: experience from a surgical help program.

    World journal of surgery·2008
    Same author

    [Oocyte and embryo quality: do the apoptotic markers have a place in the preimplantation genetic diagnostic?].

    Gynecologie, obstetrique & fertilite·2008
    Same author

    [Could apoptotic markers help the exploration of male infertility?].

    Gynecologie, obstetrique & fertilite·2008
    Same author

    ETV6 mutations and loss in AML-M0.

    Leukemia·2008
    Same journal

    Double-blind comparison of the efficacy of diclofenac/misoprostol and diclofenac in the treatment of rheumatoid arthritis.

    European journal of rheumatology and inflammation·1994
    Same journal

    Multi-centre double-blind study to define the most favourable dose of nimesulide in terms of efficacy/safety ratio in the treatment of osteoarthritis.

    European journal of rheumatology and inflammation·1994
    Same journal

    Double-blind, randomised, multi-centre clinical study evaluating the efficacy and tolerability of nimesulide in comparison with etodalac in patients suffering from osteoarthritis of the knee.

    European journal of rheumatology and inflammation·1994
    Same journal

    Comparison of the anti-inflammatory activity and gastrointestinal irritancy of nabumetone, ibuprofen, and diclofenac in rats following chronic administration.

    European journal of rheumatology and inflammation·1994
    Same journal

    Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac.

    European journal of rheumatology and inflammation·1994
    Same journal

    Prognostic significance of synovial fluid analysis in estimating the efficacy of intra-articular corticosteroid injection in patients with spondylarthropathy.

    European journal of rheumatology and inflammation·1994
    See all related articles

    Area of Science:

    • Pharmacology
    • Rheumatology
    • Clinical Trials

    Background:

    • Osteoarthritis (OA) is a prevalent degenerative joint disease.
    • Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for OA pain management.
    • Carprofen is an NSAID with established anti-inflammatory and analgesic properties.

    Purpose of the Study:

    • To evaluate the efficacy and tolerability of carprofen in patients with osteoarthritis.
    • To compare carprofen with ibuprofen in OA patients.
    • To assess the effectiveness of different carprofen dosing regimens.

    Main Methods:

    • Two randomized, double-blind trials were conducted.
    • Trial 1: Carprofen vs. ibuprofen in 20 OA patients over 8 weeks.
    • Trial 2: Two carprofen schedules (bid vs. tid) in 20 OA patients over 4 weeks.

    Related Experiment Videos

    Main Results:

    • Carprofen was found to be effective and well-tolerated in both trials.
    • A slight trend favoring carprofen efficacy over ibuprofen was observed.
    • The twice-daily (bid) carprofen schedule showed slight superiority compared to the three-times-daily (tid) regimen.

    Conclusions:

    • Carprofen is an effective and safe treatment option for osteoarthritis.
    • A bid dosing schedule may offer a slight efficacy advantage over tid dosing.
    • Further research could explore optimal carprofen dosing strategies in OA.